NasdaqCM - Delayed Quote USD

Celcuity Inc. (CELC)

13.05
+1.27
+(10.78%)
At close: June 6 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
126,906.95
113,266.95
66,230.33
39,391.09
28,355.92
Operating Income
-126,906.95
-113,266.95
-66,230.33
-39,391.09
-28,355.92
Net Non Operating Interest Income Expense
-257.15
1,487.85
2,451.22
-978.95
-1,249.09
Other Income Expense
--
--
--
--
-0.26
Pretax Income
-127,164.11
-111,779.11
-63,779.12
-40,370.04
-29,605.27
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-127,164.11
-111,779.11
-63,779.12
-40,370.04
-29,605.27
Diluted NI Available to Com Stockholders
-127,164.11
-111,779.11
-63,779.12
-40,370.04
-29,605.27
Basic EPS
-3.05
--
-2.69
-2.64
-2.21
Diluted EPS
-3.05
--
-2.69
-2.64
-2.21
Basic Average Shares
41,809.57
--
23,679.47
15,418.54
13,382.55
Diluted Average Shares
41,809.57
--
23,679.47
15,418.54
13,382.55
Total Operating Income as Reported
-126,906.95
-113,266.95
-66,230.33
-39,391.09
-28,355.92
Total Expenses
126,906.95
113,266.95
66,230.33
39,391.09
28,355.92
Net Income from Continuing & Discontinued Operation
-127,164.11
-111,779.11
-63,779.12
-40,370.04
-29,605.27
Normalized Income
-127,164.11
-111,779.11
-63,779.12
-40,370.04
-29,605
Interest Income
11,805.29
11,768.29
7,777.60
1,127.16
13.26
Interest Expense
12,062.45
10,280.45
5,326.39
2,106.11
1,262.35
Net Interest Income
-257.15
1,487.85
2,451.22
-978.95
-1,249.09
EBIT
-115,101.66
-101,498.66
-58,452.73
-38,263.93
-28,342.92
EBITDA
-114,964.71
-101,368.71
-58,309.96
-38,053.01
-28,039.68
Reconciled Depreciation
136.95
129.95
142.77
210.92
303.24
Net Income from Continuing Operation Net Minority Interest
-127,164.11
-111,779.11
-63,779.12
-40,370.04
-29,605.27
Total Unusual Items Excluding Goodwill
--
--
--
0
-0.26
Total Unusual Items
--
--
--
0
-0.26
Normalized EBITDA
-114,964.71
-101,368.71
-58,309.96
-38,053.01
-28,039.42
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/20/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IDYA IDEAYA Biosciences, Inc.
21.73
+2.99%
 
NUVL Nuvalent, Inc.
78.02
-0.09%
 
IMTX Immatics N.V.
5.97
+3.29%
 
ANAB AnaptysBio, Inc.
23.70
+12.11%
 
TYRA Tyra Biosciences, Inc.
10.55
+3.74%
 
BCAX Bicara Therapeutics Inc.
11.50
+4.26%
 
MLYS Mineralys Therapeutics, Inc.
16.12
+3.20%
 
DSGN Design Therapeutics, Inc.
4.0100
+0.25%
 
CGEM Cullinan Therapeutics, Inc.
9.08
+3.89%
 
COGT Cogent Biosciences, Inc.
6.80
+13.52%